Dasatinib Drugs Market Forecast To Witness Considerable Growth From 2023 To 2030
The dasatinib drugs market comprises oral medications used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatinib is a kinase inhibitor targeted against Bcr-Abl and Src family kinases approved for the treatment of newly diagnosed adult CML patients. It demonstrates high rates of durable cytogenetic and molecular responses....
0 Yorumlar
0 hisse senetleri